US Supreme Court hears case that could decide future of personalized medicine
This article was originally published in Scrip
Executive Summary
There's much more at stake in the outcome of a case before the US Supreme Court, which is hearing oral arguments today, than just the question of whether Prometheus Laboratories' PRO-PredictRx test for determining proper dosing of thiopurines is patentable.